UCB - Equity Capital And Reserves


UCB reported EUR10.87B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Alcon AG USD 21.6B 538M Jun/2026
Almirall EUR 1.53B 43.26M Jun/2026
Amarin USD 444.41M 796K Sep/2026
argenx SE USD 8.42B 1.09B Jun/2026
AstraZeneca USD 51.73B 1.43B Sep/2026
Bayer EUR 29.18B 533M Sep/2026
Genmab DKK 5.96B 275M Jun/2026
GlaxoSmithKline GBP 18.75B 1.11B Sep/2026
GRIFOLS EUR 5.79B 2.19B Sep/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Lakefront Biotherapeutics EUR 3.26B 10.26M Jun/2026
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 30.17B 430M Jun/2026
Novartis USD 37.23B 4.72B Sep/2026
Orion EUR 1.4B 129.5M Sep/2026
Recordati EUR 2.13B 70.34M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sanofi EUR 72.88B 3.31B Sep/2026
UCB EUR 10.87B 1.18B Dec/2025
Unibail Rodamco EUR 15.9B 559M Dec/2025